Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AVAPRITINIB vs LEVACETYLLEUCINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AVAPRITINIB vs LEVACETYLLEUCINE: Safety Overview

Metric AVAPRITINIB LEVACETYLLEUCINE
Total FAERS Reports 10,117 48
Deaths Reported 302 1
Death Rate 3.0% 2.1%
Hospitalizations 942 1
Average Patient Age 62.4 yrs 24.6 yrs
% Female Patients 56.5% 44.9%
FDA Approval Date Jan 9, 2020 Sep 24, 2024
Manufacturer Blueprint Medicines Corporation IntraBio Inc
Route ORAL ORAL
Marketing Status Prescription Prescription